Follitropin is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 while the beta subunit is glyco...
In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use...
Investigational site (there may be other sites in this country), Tokyo, Japan
BeniSuef University hospitals, BeniSuef, Egypt
Cairo University Hospitals, Cairo, Egypt
BeniSuef University hospitals, BeniSuef, Egypt
Cairo University Hospitals, Cairo, Egypt
Center for Human Reproduction, New York, New York, United States
Michigan Reproductive Medicine, Bloomfield Hills, Michigan, United States
Universitätsklinik für Frauenheilkunde, Bern, Be, Switzerland
IRCCS San Raffaele, Milan, Italy
Universitair Ziekenhuis Brussel, Brussels, Belgium
Glycotope Investigational Site, Tapolca, Hungary
Glycotope Investigational Medical Director, Bielefeld, Germany
Research Center for Genetics and Reproductive Health, Ho Chi Minh, Vietnam
UMC Utrecht, Utrecht, PO box 85500, Netherlands
Catharina Ziekenhuis, Eindhoven, PO box 1350, Netherlands
st Elizabeth Gasthuis, Tilburg, PO box 90151, Netherlands
Bashamichi Ladies Clinic, Kanagawa, Japan
Hanabusa Women's Central Fertility Clinic, Hyogo, Japan
Sophia Ladies Clinic, Kanagawa, Japan
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.